Today's Date: August 5, 2021
Report: More than 3M Texas Homes Sold, $112K increase in Median Price from 2011 to 2020   •   AARP Awards Four Utah Organizations With Community Grants as Part of Its Successful Nationwide Program   •   Jimmy Placa of Davion Inc. Wins EY Entrepreneur of the Year 2021 New Jersey Award   •   Swvl To Enhance Board With Appointment Of Three Highly Accomplished Women & Tech Leaders   •   Majority of Parents Say COVID-19 Child Care Duties Have Hurt Their Careers   •   Regions Next Step Expands Financial Wellness Offerings for Students via iGrad and WeAreTeachers Platforms   •   Essilor Vision Foundation and Vision Source® Announce Charitable Partnership   •   Proud Moments ABA recognized with Two-Year BHCOE Accreditation   •   Media Advisory - Government of Canada to increase opportunities for Indigenous businesses   •   Sagent Partners With National Association Of Minority Mortgage Bankers Of America (NAMMBA) to Further Diversity in Mortgage Serv   •   Texas Original Compassionate Cultivation Drives Over 180,000 Miles to Deliver Medical Cannabis Across Texas   •   Eagle Hill Consulting Announces Women's Business Enterprise Certification   •   CATMEDIA Adds Another Silver Telly Award to Its Trophy Case   •   General Assembly Pizza Launches New Website, Expanded eCommerce Offerings   •   HITN, Teachley and Sirius Thinking to Produce Game-Changing Narratives for Bilingual Math Education   •   Greenwood Launches Greenwood Studio to Produce Finance and Business Shows and Podcasts for Black and Latino Audience   •   Jeunesse Awarded 7 Globee Awards in 2021 Golden Bridge Competition   •   Vericast Back-to-School Survey Finds Parents Eager to Spend   •   Ontario Bioscience Innovation Organization Supports Advancement of Women in the Business of Health Science With Six-Day Bootcamp   •   Adopt a Cow program brings dairy education to the classroom; Wisconsin enrollment is open
Bookmark and Share

Life Whisperer launches its third global IVF clinic collaboration at ESHRE to apply Artificial Intelligence to Oocytes

Life Whisperer launches its third global IVF clinic collaboration at ESHRE to apply Artificial Intelligence to Oocytes

PR Newswire

LONDON, June 25, 2021 /PRNewswire/ -- Life Whisperer, fertility arm of AI healthcare company Presagen, will invite clinics to participate in its third global IVF clinic collaboration at the 37th European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting in June 2021. The AI Open Project aims to apply AI to the assessment of oocytes, or female eggs prior to fertilization or freezing. Oocyte evaluation will be Life Whisperer's third IVF product.

Life Whisperer's first two IVF products, also developed in collaboration with clinics globally, evaluate embryo quality. AI is used to non-invasively and instantly assesses embryo viability and genetics using only a single image.

Life Whisperer Viability assesses implantation potential and the likelihood of clinical pregnancy, performing 25% better than embryologist's manual assessment and reducing time to pregnancy by 15%. Life Whisperer Genetics assesses the likelihood of the embryo being genetically normal (euploid) and provides patients an alternative to invasive PGT-A genetic testing. Both products are CE-Marked and are authorized to sell to two thirds of the world's IVF market.

Life Whisperer CEO and Co-founder, Dr Michelle Perugini said, "For clinics, Life Whisperer improves standardization, efficiency, and success rates, and allows clinics to service more patients with greater confidence. For patients, Life Whisperer provides greater transparency, with a personalized report providing an objective evidence-based assessment."

Life Whisperer will have a significant scientific presence at the prestigious ESHRE virtual conference, presenting the latest developments in the application of AI to support IVF treatment. Life Whisperer has one oral presentation, and four posters featuring leading global IVF clinics including Ovation Fertility USA, IVF Life Europe, and Astra Fertility Canada.

Life Whisperer will also be exhibiting to promote its new Life Whisperer Genetics product and invite clinics, of any size and location, to contribute to its third global collaboration for Oocytes. Clinics that contribute to the Oocyte project will receive royalties on product sales.

Life Whisperer's Co-Founder Dr Jonathan Hall said, "We aim to keep developing new AI products to enhance and improve the whole IVF treatment process, and hence patient outcomes. We are excited about this product assessing oocytes, which not only can assist with IVF treatment, but can be applied to the egg freezing market, allowing female patients to have greater confidence that their eggs they are freezing will lead to a viable embryo and ultimately a pregnancy."


Headquartered in Australia and with offices in San Francisco and London, Presagen is an artificial intelligence (AI) healthcare company focused on building scalable AI products to improve women's healthcare outcomes globally. Presagen changes the way the global medical data is connected to build and deliver affordable, accessible, AI-enabled healthcare products. Its platform, The Social Network for Healthcare, connects a global collaborative network of clinics and their diverse medical data to create scalable and unbiased AI products. Presagen's flagship fertility products are branded Life Whisperer and focus on the application of AI to improve IVF outcomes for couples struggling with fertility.

Cision View original content:

SOURCE Presagen

Back to top
| Back to home page

White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News